Parallel Bio Appoints Ari Gesher As Head of Technology

Jun 26, 2024•about 1 year ago

Position

Chief Executive Officer

Company

Parallel Bio

Robert DiFazio

Cambridge

Description

Ari Gesher has joined Parallel Bio as the first head of technology. He will oversee technical infrastructure and the development of advanced AI and robotics infrastructure to rapidly scale its immune organoid platform for drug discovery. He will work with the co-founders on advancing its immune system platform.

Company Information

Company

Parallel Bio

Location

Cambridge, Maryland, United States

About

Parallel Bio unlocks the human body’s own power to cure disease. It developed the first platform that replicates the human immune system in a dish for drug discovery and development. It models human disease more realistically and accurately than animal testing—leading to the fastest path to treatments and cures that work for more people. Through its combination of immune organoids, machine learning and robotics, the platform represents the complexity of disease and the diversity of patients at population scale. Based in Cambridge, Mass., the company was founded in 2021 by two scientists responsible for creating the world’s first scalable human immune organoid. Learn more at https://www.parallel.bio.

Related People

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months